Accelerating and Streamlining CLM Content Creation
11 Dec 2025 by Isabella Coupland
Industry data shows that life sciences organisations now create significantly more digital content than traditional print materials, highlighting the growing demand for multichannel engagement. As content becomes more complex and personalised, traditional review and approval approaches are no longer sufficient. To keep pace, organisations must streamline workflows to ensure digital content is created, reviewed and distributed more efficiently.
1. Improve Content Quality Through Clear Objectives and Early Planning
A clear brief and shared understanding of content objectives are critical to successful content creation. Investing time in the early planning and pre-approval stages helps ensure that assets are focused, aligned and fit for purpose.
Using prototypes or draft layouts as part of early discussions with medical, legal and regulatory (MLR) teams can provide valuable early guidance and highlight potential compliance challenges. This early alignment helps ensure smoother reviews and enables faster progression through the approval process, ultimately accelerating time to market.
2. Utilise Real-Time Insights and Data
Visibility into content workflows is essential for improving efficiency. Real-time insights allow teams to identify bottlenecks, understand review timelines and take corrective action where delays occur.
Tracking metrics such as time from initial draft to approval provides a clear view of review cycle performance. Content reuse across global and local markets can also be monitored, helping organisations identify which assets deliver the greatest value and have the strongest potential for reuse.
These insights enable global teams to refine content planning, improve reuse strategies and feed learnings back into the creation process. Low adoption in specific markets or regions can be investigated early, allowing teams to adjust content or processes accordingly.
3. Tailor Content Reviews for Local Markets
Local regulatory and compliance requirements introduce additional complexity into the content review process. Without visibility, it can be difficult to track changes and understand how local adaptations impact timelines and reuse.
By recording review and approval metrics at a local level, organisations gain greater insight into regional challenges. This allows teams to collaborate more effectively, set realistic approval timelines and adapt global master content to better support local market needs.
4. Harness the Power of Modular Content
The growth of digital engagement, combined with an expanding number of channels and the demand for personalised communication, has significantly increased the pressure on content creation and approval workflows.
Modular content offers a scalable solution. By breaking larger assets, such as CLM presentations, into smaller, reusable modules linked to approved claims or references, teams can significantly accelerate review cycles.
Reusing pre-approved modules often removes the need for full re-review, reducing approval timelines and production effort.
Modular approaches also enable teams to build new content using existing approved components, improving consistency, reducing costs and supporting faster localisation across markets.
How PULSE Can Help
At PULSE, we help life sciences teams streamline global-to-local content creation through modular content strategies and efficient approval workflows. Our Heartbeat™ content authoring platform supports scalable, compliant content creation, localisation and reuse across regulated delivery environments.
Get in touch to learn how a modular content approach, supported by Heartbeat™, can help accelerate approvals, improve efficiency and drive more effective digital engagement.
Isabella Coupland
I am the Communications Lead at PULSE and I help generate awareness around our solutions. I am passionate about how communications help support our customers in achieving their business objectives.
I have a particular interest in the end to end content supply chain for global pharmaceutical customers; I take a keen interest in the burgeoning trends of healthcare, supported and delivered by digital and its associated technologies.
Working in an innovative and fast-paced industry, I strive to ensure that our communications are clear and focus on the value we create for healthcare professionals, patients, consumers, and shoppers.
